Psychiatry · Lynn, MA
NPI
1437178993
Since 2006
Specialty
Psychiatry
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
173 Oxford St
Lynn, MA, 01901
Phone (781) 268-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$130K
1,416 services
Medicare patients, 2024
166
Average age 56
Drug cost, 2024
$984K
9,668 prescriptions
Company payments, 2025
$3,911
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by J P Reimherr was code 99214 (office e&m - established), 841 times for 153 patients. In total J P Reimherr billed 1,416 services in 8 codes, and Medicare paid $130K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 841 | 153 | $100.06 | $84K |
| 99442 Telephone Services | Office | 386 | 130 | $47.48 | $18K |
| 99213 Office E&M - Established | Office | 49 | 29 | $73.40 | $3,597 |
By year: 2022 $147K for 2,181 services; 2023 $129K for 1,810 services; 2024 $130K for 1,416 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 24 | 19 | $12.35 | $296 |
Medicare prescription drug claims, 2024
In 2024, the drug J P Reimherr prescribed most often to Medicare patients was Clonazepam, with 886 prescriptions and refills. In total J P Reimherr wrote 9,668 Medicare prescriptions that cost $984K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 886 | 902 | 95 | $9,534 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 720 | 721 | 83 | $23K |
| Alprazolam Generic | 598 | 620 | 71 | $7,078 |
| Gabapentin Generic | 578 | 600 | 65 | $11K |
| Quetiapine Fumarate Generic | 349 | 405 | 46 | $8,222 |
| Lorazepam Generic | 324 | 330 | 41 | $3,756 |
| Fluoxetine Hcl Generic | 290 | 365 | 41 | $2,331 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 280 | 280 | 32 | $43K |
| Prazosin Hcl Generic | 264 | 322 | 30 | $4,213 |
| Diazepam Generic | 259 | 265 | 33 | $3,229 |
| Clonidine Hcl Generic | 254 | 276 | 33 | $1,767 |
| Trazodone Hcl Generic | 234 | 249 | 35 | $1,873 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 232 | 234 | 32 | $20K |
| Lamotrigine Generic | 222 | 271 | 34 | $2,479 |
| Risperidone Generic | 191 | 267 | 29 | $2,280 |
Brand drugs: 672 claims; generic drugs: 8,996 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid J P Reimherr $3,911 ($3,911 in general payments such as food, travel and fees) from 17 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $665.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 30 | $665 |
| Abbvie Inc. ABBV | 30 | $531 |
| Neurocrine BioSciences, Inc. NBIX | 15 | $393 |
| Lundbeck LLC | 12 | $364 |
| Teva Pharmaceuticals USA, Inc. TEVA | 14 | $355 |
| Janssen Pharmaceuticals, Inc JNJ | 10 | $330 |
| Alkermes, Inc. ALKS | 12 | $250 |
| E.R. Squibb & Sons, L.L.C. BMY | 13 | $241 |
| Axsome Therapeutics, Inc. AXSM | 16 | $239 |
| Vanda Pharmaceuticals Inc. VNDA | 17 | $218 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.